Efficacy and safety of the SARS-CoV-2 mRNA vaccine in lung transplant recipients: a possible trigger of rejection

OBJECTIVE: Solid organ transplant recipients have an increased risk of developing severe coronavirus disease 2019 (COVID-19). Although SARS-CoV-2 mRNA vaccination has been strongly recommended for solid organ transplant recipients, its efficacy and safety have remained unknown. METHODS: We performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Goda, Yasufumi, Nakajima, Daisuke, Tanaka, Satona, Yamada, Yoshito, Yutaka, Yojiro, Unagami, Kohei, Yoshikawa, Mikiko, Egawa, Hiroto, Date, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607698/
https://www.ncbi.nlm.nih.gov/pubmed/36289168
http://dx.doi.org/10.1007/s11748-022-01887-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607698/
https://www.ncbi.nlm.nih.gov/pubmed/36289168
http://dx.doi.org/10.1007/s11748-022-01887-3

Ejemplares similares